Triacontanol
CAS No. 28351-05-5
Triacontanol( —— )
Catalog No. M18360 CAS No. 28351-05-5
1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 100MG | 140 | In Stock |
|
| 200MG | 252 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTriacontanol
-
NoteResearch use only, not for human use.
-
Brief Description1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax.
-
Description1-Triacontanol is a fatty alcohol of the general formula C30H62O, also known asmelissyl alcoholormyricyl alcohol. It is found in plantcuticle waxesand inbeeswax. Triacontanol is agrowth stimulantfor many plants, most notablyroses, in which it rapidly increases the number of basal breaks.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28351-05-5
-
Formula Weight438.82
-
Molecular FormulaC30H62O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li X, et al. Bioorg Med Chem Lett. 2011, 21(18):5251-4.
molnova catalog
related products
-
Bupivacaine hydrochl...
Bupivacaine hydrochloride binds to the intracellular portion of voltage-gated sodium channels and blocks sodium influx into nerve cells.
-
AH 6809
AH 6809 is an antagonist of EP and DP receptor(with Kis of 1217, 1150, 1597, and 1415 nM for the cloned human EP1, EP2, EP3-III, and DP receptor respectively).
-
Tafluprost
Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic pattern.
Cart
sales@molnova.com